Giris ve Amaç:Bu çalisma ile, COVID-19 pandemisinin in?amatuvar bagirsak hastaligi olan bireylerin yasam kalitesi, hastalik aktivitesive anksiyete düzeyleri üzerindeki etkilerinin degerlendirilmesi amaçlanmaktadir.Gereç ve Yöntem:Çalisma, Gazi Üniversitesi Gastroenteroloji Polikliniginde, 62 in?amatuvar bagirsak hastasi ve 60 saglikli bireyden olusan bir kontrol grubuyla gerçeklestirilmistir. Katilimcilara, Beck AnksiyeteÖlçegi ve Dünya Saglik Örgütü Yasam Kalitesi Ölçegi uygulanmistir. In?amatuvar bagirsak hastalarinin hastalik aktivitesi, Crohn Hastaligi AktiviteIndeksi ve Mayo Klinik Skoru ile degerlendirilmistir.Bulgular:In?amatuvar bagirsak hastalarinin genel saglik, ?ziksel, psikolojik ve sosyal alan- lardaki yasam kalitesi puanlarinin kontrol grubuna kiyasla anlamli derecede düsük oldugu bulunmustur (p < 0.05). Çevresel alan puanlarinda iseanlamli bir fark tespit edilmemistir. Anksiyete düzeyleri, in?amatuvar bagirsak hastaligi grubunda belirgin bir artis göstermis ve hastalik aktivitesi ilepozitif korelasyon göstermistir. Hastalarin %80.6’si COVID-19’un hastaliklariyla ilgili risk olusturdugunu belirtmis, %35.5’i hastane takiplerini aksat-mis ve %11.3’ü ilaçlarini birakmistir. Ayrica, hastalik aktivitesi ile yasam kalitesi arasinda negatif bir iliski oldugu, buna karsin anksiyete düzeyi ile pozitif bir iliski oldugu saptanmistir.Sonuç:COVID-19 pandemisi in?amatuvar bagirsak hastalarinin yasam kalitesinde belirgin bir düsüse ve anksiyete düzeylerinde artisa neden olmustur. Hastalik aktivitesinin, bu etkilerde belirgin bir rol oynadigi tespit edilmistir. Bu bulgular, hasta-hekim iletisiminin güçlendirilmesi, teletip uygulamalarinin yayginlastirilmasi ve psikososyal destek saglanmasinin önemini ortaya koymaktadir. Olaganüstü durumlarda in?amatuvar bagirsak hastaligi yönetimine yönelik yeni stratejilerin gelistirilmesi gerekliliginin mevcut oldugu düsünülmüstür.
Background and Aims:This study aims to evaluate the impact of the COVID-19 pandemic on the quality of life, disease ac-tivity, and anxiety levels of individuals with in?ammatory bowel disease.Materials and Methods:The study was conducted at Gazi University Gastroenterology Outpatient Clinic with 62 in?ammatory bowel disease patients and 60 healthy individuals as a control group. Participants wereassessed using the Beck Anxiety Inventory and the World Health Organization Quality of Life Scale. Disease activity in in?ammatory bowel dis-ease patients was evaluated using the Crohn’s Disease Activity Index and the Mayo Clinical Score.Results:The quality of life scores in general health, physical, psychological, and social domains were signi?cantly lower in in?ammatory bowel disease patients compared to the control group(p < 0.05), while no signi?cant difference was found in the environmental domain. Anxiety levels were signi?cantly higher in the in?ammatorybowel disease group and positively correlated with disease activity. Of the patients, 80.6% considered COVID-19 a risk for their condition, 35.5%missed follow up appointments, and 11.3% discontinued their medications. Moreover, a negative correlation was found between disease activity and quality of life, while a positive correlation was observed between disease activity and anxiety levels.Conclusion:The COVID-19 pandemichas led to a signi?cant decline in the quality of life and an increase in anxiety levels among in?ammatory bowel disease patients. Disease activityhas played a critical role in these effects. These ?ndings highlight the importance of strengthening doctor-patient communication, expanding tele medicine applications, and providing psychosocial support. The study suggests the need for developing new strategies for in?ammatory bowel disease management during extraordinary situations.